Jon joined Neuren in 2013 as CFO and has been CEO since May 2020. He has played a central role in all aspects of Neuren's R&D, commercial and corporate activities for 10 years. Before joining Neuren he was a member of the leadership team at Acrux throughout a period that included Acrux's IPO and listing on the ASX, the development and FDA approval of three novel pharmaceutical products and a transforming licensing deal with Eli Lilly in 2010.

He formerly spent seven years in a series of senior financial positions in the R&D and corporate functions of international pharmaceutical groups Medeva and Celltech, which are now part of UCB. Jon is a Chartered Accountant and holds a degree in Biotechnology from the University of Reading in the UK.

Greg Macpherson is a pharmacist, biotechnologist, cellular health expert and author of, Harnessing the Nine Hallmarks of Ageing: to live your healthiest life. For more than a decade, he has been working in the biotechnology sector, specifically focusing on the ageing process at the cellular level.

This work led him to discover ways to harness the nine identified, scientific hallmarks of ageing, which is the premise of his book that addresses the natural ageing process, how to age more favourably and simple strategies to slow the ageing process and build a functional healthspan.

Macpherson founded SRW Laboratories, a science and research based company that curates the latest biotechnology research to formulate natural products designed to help slow the onset of ageing and disease, and develop evidence based solutions for those who are experiencing age-related health concerns or who want to improve their healthspan.

With ageing being the single biggest risk factor for developing disease, Macpherson’s mission to slow the ageing process at a cellular level could help millions of people delay the onset of diseases associated with advanced ageing like Alzheimer’s and heart disease and increase healthspan.